Understanding how planarians regenerate their brain and nerve cells
Mechanisms Driving Regenerative Neurogenesis in Planarians
['FUNDING_R01'] · UNIVERSITY OF GEORGIA · NIH-11090352
This study looks at how planarians, a type of flatworm, can regrow their brains and nerve cells after getting hurt, and it aims to find out what helps them do this so we can learn how to improve brain healing in people with conditions like neurodegenerative diseases or injuries.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF GEORGIA (nih funded) |
| Locations | 1 site (ATHENS, UNITED STATES) |
| Trial ID | NIH-11090352 on ClinicalTrials.gov |
What this research studies
This research investigates the remarkable ability of planarians, a type of freshwater flatworm, to regenerate their brain and nerve cells after injury. By studying these organisms, researchers aim to uncover the molecular and cellular mechanisms that enable effective neural regeneration. The project focuses on identifying key factors that promote the growth of new neurons from adult stem cells, particularly dopaminergic neurons, and how environmental cues influence this process. Insights gained from this research could inform strategies for enhancing brain repair in humans following neurodegenerative diseases or injuries.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals recovering from strokes or those with neurodegenerative conditions.
Not a fit: Patients with acute brain injuries that do not involve regenerative processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in regenerative medicine, offering new treatments for brain injuries and neurodegenerative diseases in humans.
How similar studies have performed: Previous research has shown promise in understanding regeneration in other species, but the specific mechanisms in planarians remain largely untested.
Where this research is happening
ATHENS, UNITED STATES
- UNIVERSITY OF GEORGIA — ATHENS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROBERTS-GALBRAITH, RACHEL HELEN — UNIVERSITY OF GEORGIA
- Study coordinator: ROBERTS-GALBRAITH, RACHEL HELEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.